# Pfizer Inc. – FDA Inspection, Sep 29, 2026

Source: https://www.keypedia.com/records/fda_inspections/pfizer-inc/4057bc9d-ffe0-4d70-ab21-41af1cfacb04
Source feed: FDA_Inspections

> FDA inspection 1338628 of Pfizer Inc., September 29, 2026. 1 citation. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1338628
- Company Name: Pfizer Inc.
- Inspection Date: 2026-09-29
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1256978 - 2025-06-18
- FDA Inspection 1181324 - 2022-09-28
- FDA Inspection 971684 - 2016-06-02
- FDA Inspection 847159 - 2013-09-05
- FDA Inspection 714537 - 2011-03-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)
- [Investigator](https://www.keypedia.com/people/logan-m-jones/286ab813-461a-4bfc-a732-bcd4f0d6e596)

Company: https://www.keypedia.com/companies/pfizer-inc/95f0f34c-638b-4a6b-8c65-35fb37711e6b

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248